 "Nestle India gains as Maggi noodles clear laboratory tests")
Nestle India has moved higher by 8% to Rs 6,675 on the BSE after the company said that the Maggi noodles are safe and 100% of samples tested by three laboratories are clear.
“We have received test results from all three laboratories mandated by the Hon’ble Bombay High Court to test Maggi noodles samples. All the 90 samples, covering 9 variants, tested by the laboratories are clear with lead much below the permissible limits,” Nestle India said in a press release.
Nestle India has conducted over 3500 tests representing over 200 million packs in both national as well as international accredited laboratories and all reports are clear, it added.
The company said it is committed to reintroduce Maggi noodles at the earliest.
“Nestle will continue to collaborate with the Food Safety and Standards Authority of India (FSSAI), the apex food regulator and other stakeholders. In compliance with the orders of the Hon’ble Bombay High Court, we will now commence manufacture and will start selling only after the newly manufactured products are also cleared by the designated three laboratories,” it added.
At 02:06 pm, the stock was up 7% at Rs 6,619 as compared to 0.10% fall in the Sensex. A combined 209,761 shares changed hands on the counter on the BSE and NSE.
“We have received test results from all three laboratories mandated by the Hon’ble Bombay High Court to test Maggi noodles samples. All the 90 samples, covering 9 variants, tested by the laboratories are clear with lead much below the permissible limits,” Nestle India said in a press release.
Nestle India has conducted over 3500 tests representing over 200 million packs in both national as well as international accredited laboratories and all reports are clear, it added.
The company said it is committed to reintroduce Maggi noodles at the earliest.
“Nestle will continue to collaborate with the Food Safety and Standards Authority of India (FSSAI), the apex food regulator and other stakeholders. In compliance with the orders of the Hon’ble Bombay High Court, we will now commence manufacture and will start selling only after the newly manufactured products are also cleared by the designated three laboratories,” it added.
At 02:06 pm, the stock was up 7% at Rs 6,619 as compared to 0.10% fall in the Sensex. A combined 209,761 shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%